Akt Activation Is Important In KRAS-Mediated Multistep Leukemogenesis

被引：0
作者：
Ward, Ashley F. [1 ]
Shieh, Angell [1 ]
Harding-Theobald, Emily Rose [1 ]
Bollag, Gideon [2 ]
Shannon, Kevin [1 ]
机构：
[1] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA
[2] Plexxikon Inc, Berkeley, CA USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1707 / 1707
页数：1
相关论文
共 50 条
  • [31] G9a Responds to KRAS-Mediated Replication Stress by Increased Origin Licensing
    Thomas, Anju
    De Assuncao, Thiago Milech
    Lomberk, Gwen
    FASEB JOURNAL, 2022, 36
  • [32] Oncogenic KRAS-mediated epigenetic reprogramming is altered by loss of Activating Transcription Factor 3
    Mousavi, Fatemeh
    Pin, Christopher L.
    Shooshtari, Parisa
    CANCER RESEARCH, 2024, 84 (17)
  • [33] Differential Effects of Dietary Macronutrients on the Development of Oncogenic KRAS-Mediated Pancreatic Ductal Adenocarcinoma
    Zhu, Liang
    Ji, Juntao
    Ma, Jianjia
    Wang, Dan
    Liu, Muyun
    Du, James Xianxing
    Chen, Rong
    Hou, Wei
    Abbruzzese, James L.
    Logsdon, Craig D.
    Yang, Vincent W.
    Luo, Yongde
    Lu, Weiqin
    CANCERS, 2022, 14 (11)
  • [34] RBPJ Deficiency Sensitizes Pancreatic Acinar Cells to KRAS-Mediated Pancreatic Intraepithelial Neoplasia Initiation
    Pan, Leiling
    Mulaw, Medhanie A.
    Gout, Johann
    Guo, Min
    Zarrin, Hina
    Schwarz, Peggy
    Baumann, Bernd
    Seufferlein, Thomas
    Wagner, Martin
    Oswald, Franz
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2023, 16 (05): : 783 - 807
  • [35] Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancer
    Kyle Knickelbein
    Jingshan Tong
    Dongshi Chen
    Yi-Jun Wang
    Sandra Misale
    Alberto Bardelli
    Jian Yu
    Lin Zhang
    Oncogene, 2018, 37 : 4599 - 4610
  • [36] Deficient Rnf43 potentiates hyperactive Kras-mediated pancreatic preneoplasia initiation and malignant transformation
    Xian Zhou
    Zhichao Sun
    Mengdi Zhang
    Xiaoyu Qu
    Shuhui Yang
    Lianmei Wang
    Yanling Jing
    Li Li
    Weiwei Deng
    Fangming Liu
    Jin Di
    Jie Chen
    Jian Wu
    Hongbing Zhang
    AnimalModelsandExperimentalMedicine, 2022, 5 (01) : 61 - 71
  • [37] Correction: ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis
    Katarzyna Bogucka
    Federico Marini
    Sebastian Rosigkeit
    Janine Schloeder
    Helmut Jonuleit
    Kerstin David
    Margarita Schlackow
    Krishnaraj Rajalingam
    Cancer Gene Therapy, 2021, 28 (5) : 543 - 543
  • [38] Carnosine inhibits KRAS-mediated HCT116 proliferation by affecting ATP and ROS production
    Iovine, Barbara
    Iannella, Maria Luigia
    Nocella, Francesca
    Pricolo, Maria Rosaria
    Bevilacqua, Maria Assunta
    CANCER LETTERS, 2012, 315 (02) : 122 - 128
  • [39] The KRASG12D inhibitor MRTX1133 elucidates KRAS-mediated oncogenesis
    Christensen, James G.
    Hallin, Jill
    NATURE MEDICINE, 2022, 28 (10) : 2017 - 2018
  • [40] The KRASG12D inhibitor MRTX1133 elucidates KRAS-mediated oncogenesis
    Nature Medicine, 2022, 28 : 2017 - 2018
12345